title: [Economic evaluation of at home subcutaneous and intravenous immunoglobulin substitution].
abstract: BACKGROUND
  Intravenous (IV) and subcutaneous (SC) immunoglobulin (Ig) administration is a safe and an efficacious treatment in patients with IgG deficiency. Home administration of IV Ig and SC Ig has recently been approved in France. Most of the patients treated in hospital ask for home treatment. Some patients prefer monthly IV administration, others weekly SC administration.
  
  
  METHODS
  We evaluated in details the cost of both of these practices. We currently use electric pumps for both IV and SC administration which are fixed to the patient giving complete freedom and mobility.
  
  
  RESULTS
  For 20 g administrated per 4 week, the total cost of home treatment is 1,518 euro with SC Ig and 1,033 euro with IV Ig. For 40 g administrated per 4 week, the total cost of home treatment is 2,507 euro to 2,729 euro with SC Ig and 2,034 euro with IV Ig. The difference is mainly explained by the cost of renting the electric pumps and by the cost of furniture for SC administration. The choice of home Ig substitution must be given to all patient receiving treatment in hospital.
  
  
  CONCLUSIONS
  Home IV and home SC perfusions are two possible options each different with there own advantages and disadvantages. The cost of each procedure must be known by the medical staff.
authors.affiliation: Pharmacie centrale, CHRU, avenue Oscar-Lambret, 59037 Lille cedex, France.
authors.forename: L
authors.initials: L
authors.lastname: Haddad
authors.forename: M
authors.initials: M
authors.lastname: Perrinet
authors.forename: D
authors.initials: D
authors.lastname: Parent
authors.forename: A
authors.initials: A
authors.lastname: Leroy-Cotteau
authors.forename: E
authors.initials: E
authors.lastname: Toguyeni
authors.forename: G
authors.initials: G
authors.lastname: Condette-Wojtasik
authors.forename: E
authors.initials: E
authors.lastname: Hachulla
mesh_terms: D003362:Cost-Benefit Analysis; D005602:France; D006699:Home Care Services / Q000191:economics*; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage* / Q000191:economics*; D016756:Immunoglobulins, Intravenous / Q000191:economics*; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy* / Q000191:economics*; D007279:Injections, Subcutaneous / Q000191:economics
chemical_list: D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous